75 related articles for article (PubMed ID: 22528229)
1. Expression and significance of SHP-2 in human papillomavirus infected cervical cancer.
Meng F; Zhao X; Zhang S
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):247-251. PubMed ID: 22528229
[TBL] [Abstract][Full Text] [Related]
2. Significance of SHP-1 and SHP-2 expression in human papillomavirus infected Condyloma acuminatum and cervical cancer.
Tao XH; Shen JG; Pan WL; Dong YE; Meng Q; Honn KV; Jin R
Pathol Oncol Res; 2008 Dec; 14(4):365-71. PubMed ID: 18543080
[TBL] [Abstract][Full Text] [Related]
3. RPRD1B is a potentially molecular target for diagnosis and prevention of human papillomavirus E6/E7 infection-induced cervical cancer: A case-control study.
Wen N; Bian L; Gon J; Meng Y
Asia Pac J Clin Oncol; 2021 Jun; 17(3):230-237. PubMed ID: 32866332
[TBL] [Abstract][Full Text] [Related]
4. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia.
Krishnappa P; Mohamad IB; Lin YJ; Barua A
Diagn Pathol; 2014 Nov; 9():202. PubMed ID: 25361681
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
[TBL] [Abstract][Full Text] [Related]
6. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
7. Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ.
Wang L; Li H; Liang F; Hong Y; Jiang S; Xiao L
Med Oncol; 2014 Sep; 31(9):143. PubMed ID: 25106529
[TBL] [Abstract][Full Text] [Related]
8. SHP-2 phosphatase promotes cervical cancer cell proliferation through inhibiting interferon-β production.
Meng F; Zhao X; Zhang S
J Obstet Gynaecol Res; 2013 Jan; 39(1):272-9. PubMed ID: 22889324
[TBL] [Abstract][Full Text] [Related]
9. Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16
Kawashita S; Matsuda K; Kondo H; Kitajima Y; Hasegawa Y; Shimada T; Kitajima M; Miura K; Nakashima M; Masuzaki H
Cancer Control; 2020; 27(1):1073274819901170. PubMed ID: 32077330
[TBL] [Abstract][Full Text] [Related]
10. High expression of ezrin predicts poor prognosis in uterine cervical cancer.
Kong J; Li Y; Liu S; Jin H; Shang Y; Quan C; Li Y; Lin Z
BMC Cancer; 2013 Nov; 13():520. PubMed ID: 24182314
[TBL] [Abstract][Full Text] [Related]
11. Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer.
Aftab M; Poojary SS; Seshan V; Kumar S; Agarwal P; Tandon S; Zutshi V; Das BC
Sci Rep; 2021 May; 11(1):10323. PubMed ID: 33990639
[TBL] [Abstract][Full Text] [Related]
12. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer.
Herfs M; Yamamoto Y; Laury A; Wang X; Nucci MR; McLaughlin-Drubin ME; Münger K; Feldman S; McKeon FD; Xian W; Crum CP
Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10516-21. PubMed ID: 22689991
[TBL] [Abstract][Full Text] [Related]
13. Cancer associated human papillomaviruses.
McLaughlin-Drubin ME; Meyers J; Munger K
Curr Opin Virol; 2012 Aug; 2(4):459-66. PubMed ID: 22658985
[TBL] [Abstract][Full Text] [Related]
14. ROLE OF MICRORNA-155 AS A DIAGNOSTIC BIOMARKER FOR HUMAN PAPILLOMAVIRUS ASSOCIATED CERVICAL CANCER.
Jihad NA; Issa YW
Wiad Lek; 2021; 74(9 cz 2):2301-2304. PubMed ID: 34824176
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of E-cadherin by human papillomavirus is not confined to high-risk, cancer-causing types.
Leong CM; Doorbar J; Nindl I; Yoon HS; Hibma MH
Br J Dermatol; 2010 Dec; 163(6):1253-63. PubMed ID: 20698848
[TBL] [Abstract][Full Text] [Related]
16. Integrin subunit β1 and laminin γ1 chain expression: a potential prognostic biomarker in cervical cancer.
Zacapala-Gómez AE; C Alarcón-Romero LD; Mendoza-Catalán MA; Salmerón-Bárcenas EG; I Zubillaga-Guerrero M; Torres-Rojas FI; Illades-Aguiar B
Biomark Med; 2020 Oct; 14(15):1461-1471. PubMed ID: 32845182
[No Abstract] [Full Text] [Related]
17. Increased Gene Expression of
Parida P; Lewis S; Sharan K; Kamal MV; Kumar NAN; Godkhindi VM; Varambally S; Rangnekar VM; Rao M; Damerla RR
Cells; 2023 Oct; 12(21):. PubMed ID: 37947608
[No Abstract] [Full Text] [Related]
18. Identification of COPA as a potential prognostic biomarker and pharmacological intervention target of cervical cancer by quantitative proteomics and experimental verification.
Bao H; Li X; Cao Z; Huang Z; Chen L; Wang M; Hu J; Li W; Sun H; Jiang X; Mei P; Li H; Lu L; Zhan M
J Transl Med; 2022 Jan; 20(1):18. PubMed ID: 34991628
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Interleukin-6 in HPV-Positive Breast Cancer Patients.
Charostad J; Azaran A; Nakhaei M; Astani A; Kaydani GA; Motamedfar A; Makvandi M
Iran J Immunol; 2021 Dec; 18(4):315-330. PubMed ID: 34931617
[TBL] [Abstract][Full Text] [Related]
20. Overview of microarray analysis of gene expression and its applications to cervical cancer investigation.
Chao A; Wang TH; Lai CH
Taiwan J Obstet Gynecol; 2007 Dec; 46(4):363-73. PubMed ID: 18182341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
